Christopher Schutta

Adenovirus Serotype 5-Vectored Foot-And-Mouth Disease Subunit Vaccines: The First Decade

Marvin J. Grubman, Mauro Pires Moraes, Christopher Schutta et al. · Future Virology · 2009 · 61 citations

Vaccination, Veterinary Vaccine, Vaccine Development +13

Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge

Christopher Schutta, José Barrera, Melia Pisano et al. · Vaccine · 2015 · 35 citations · Full text

Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.

David A. Brake, Mary M. McIlhaney, Thomas D. Miller et al. · PubMed · 2012 · 23 citations

Vaccination, Veterinary Vaccine, Vaccine Development +14

Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine

José Barrera, Christopher Schutta, Melia Pisano et al. · Vaccine · 2018 · 18 citations · Full text

Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine

José Barrera, David A. Brake, Christopher Schutta et al. · Vaccine · 2018 · 17 citations · Full text